Abeona Therapeutics Inc (ABEO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.02
(+0.45%)
After-Hours: 20:00
Abeona Therapeutics Max Drawdown (5Y): 99.58% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.58% |
March 31, 2024 | 99.58% |
February 29, 2024 | 99.58% |
January 31, 2024 | 99.58% |
December 31, 2023 | 99.58% |
November 30, 2023 | 99.58% |
October 31, 2023 | 99.58% |
September 30, 2023 | 99.58% |
August 31, 2023 | 99.58% |
July 31, 2023 | 99.58% |
June 30, 2023 | 99.58% |
May 31, 2023 | 99.58% |
April 30, 2023 | 99.58% |
March 31, 2023 | 99.58% |
February 28, 2023 | 99.58% |
January 31, 2023 | 99.55% |
December 31, 2022 | 99.55% |
November 30, 2022 | 99.48% |
October 31, 2022 | 99.48% |
September 30, 2022 | 99.48% |
August 31, 2022 | 99.36% |
July 31, 2022 | 99.36% |
June 30, 2022 | 99.36% |
May 31, 2022 | 99.36% |
April 30, 2022 | 99.04% |
Date | Value |
---|---|
March 31, 2022 | 98.96% |
February 28, 2022 | 98.96% |
January 31, 2022 | 98.96% |
December 31, 2021 | 98.66% |
November 30, 2021 | 96.99% |
October 31, 2021 | 96.22% |
September 30, 2021 | 95.24% |
August 31, 2021 | 95.24% |
July 31, 2021 | 95.24% |
June 30, 2021 | 95.24% |
May 31, 2021 | 96.80% |
April 30, 2021 | 97.79% |
March 31, 2021 | 97.79% |
February 28, 2021 | 98.15% |
January 31, 2021 | 98.15% |
December 31, 2020 | 98.15% |
November 30, 2020 | 98.29% |
October 31, 2020 | 98.29% |
September 30, 2020 | 98.29% |
August 31, 2020 | 98.29% |
July 31, 2020 | 98.29% |
June 30, 2020 | 98.29% |
May 31, 2020 | 98.29% |
April 30, 2020 | 98.29% |
March 31, 2020 | 98.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.24%
Minimum
Jun 2021
99.58%
Maximum
Feb 2023
98.53%
Average
98.32%
Median
May 2019
Max Drawdown (5Y) Benchmarks
T2 Biosystems Inc | 99.99% |
INVO Bioscience Inc | 99.83% |
Perspective Therapeutics Inc | 91.70% |
Electromed Inc | 55.84% |
Xtant Medical Holdings Inc | 98.66% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -73.39 |
Beta (5Y) | 1.592 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 90.73% |
Historical Sharpe Ratio (5Y) | -0.6134 |
Historical Sortino (5Y) | -1.101 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.09% |